GlaxoSmithKline Biologicals; Niederlassung Der Smithkline Beecham Pharma GmbH & Co. KG
发明人:
Eichhorn, Uwe,Saenger, Roland Herbert
申请号：
HRP20170480
公开号：
HRP20170480T1
申请日:
2017.03.21
申请国别(地区):
HR
年份:
2017
代理人:
摘要：
An inactivated influenza virus preparation is described which comprises a haemagglutinin antigen stabilised in the absence of thiomersal, or at low levels of thiomersal, wherein the haemagglutinin is detectable by a SRD assay. The influenza virus preparation may comprise a micelle modifying excipient, for example &alpha；-tocopherol or a derivative thereof in a sufficient amount to stabilise the haemagglutinin.
